Pharmafile Logo

19 Patient Centricity on Trial

May 28, 2019 |  

Clinical trials are broken and only patients can help us fix them. If we let them.

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. Clinical trials are the lifeblood of medicine, yet they are struggling for numbers. And without effective recruitment, the cost of producing the next generation of drugs, soars.

This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise trial design, retention and recruitment – ultimately improving outcomes.

Visit https://www.patientcentricityontrial.com/ to download your copy now.

This content was provided by Havas Lynx

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

The campaign encourages people who use drugs to do something remarkable – save a life

Andi Goes – the children’s book that helps detect early signs of dyslexia

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

Neurofibromatosis: a condition that’s hard to say, but even harder to live with

The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.